NMIBC
Clinical trials for NMIBC explained in plain language.
Never miss a new study
Get alerted when new NMIBC trials appear
Sign up with your email to follow new studies for NMIBC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for bladder cancer patients unable to join trials
Disease control AVAILABLEThis program offers a new version of the standard BCG treatment to people with non-muscle invasive bladder cancer who cannot take part in a clinical trial. It is for patients who would normally receive TICE BCG but cannot get it or join a study. The goal is to provide access to t…
Matched conditions: NMIBC
Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated May 26, 2026 06:42 UTC
-
New bacterial therapy aims to stop bladder cancer in its tracks
Disease control Recruiting nowThis study tests a new treatment for non-muscle invasive bladder cancer (NMIBC) using a modified version of the BCG bacteria, given directly into the bladder. The goal is to see if it is safe and can control the cancer, preventing it from coming back. About 40 adults who have not…
Matched conditions: NMIBC
Phase: PHASE1, PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New injection targets bladder tumors in early trial
Disease control Recruiting nowThis early-stage trial is testing a new drug called belzupacap sarotalocan (AU-011) for people with a type of bladder cancer that hasn't spread into the muscle layer. The drug is injected directly into the tumor, sometimes with a laser, to see if it's safe and possible to do. Abo…
Matched conditions: NMIBC
Phase: PHASE1 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated May 22, 2026 14:04 UTC